FICO enters September in freefall, having shed nearly a fifth of its value in a single week — yet the data tells a story of a market that is troubled, not positioned for a collapse.
The catalyst is recent and severe. FICO dropped 16.7% on September 4 alone, extending a one-week loss to 19.2% to close at $932.26. This follows a pattern that has become familiar for the stock: after the most recent earnings release on July 29, the stock fell 14.7% the next day and lost 18.3% over the following five sessions. The prior print in late July 2026 brought another 8.3% single-day drop. These are not ordinary earnings misses — FICO has a demonstrated pattern of violent post-print moves, and the September sell-off appears to extend that sequence. The next scheduled release is November 6, meaning the market now has two months to recalibrate.
The most striking feature of this week's data is how little the lending market is reacting to the price drop. Short interest in FICO is actually falling — down 19.5% over the past month to 7.5% of the free float, a meaningful but not extreme level. Borrowing costs are low at 0.47% and have eased 12% over the past week. Borrow availability is running at roughly 430% of outstanding short interest, comfortably in normal territory and near its most relaxed level of the past year. That combination — a plunging stock, falling short interest, and a loose borrow market — suggests bears are not aggressively pressing new positions here. The shorts who were in earlier have been covering, not adding. Options positioning points a different direction: the put/call ratio has jumped to 0.96, well above its 20-day average of 0.88 and running near the top of its recent range. That tilt toward puts has appeared abruptly — through mid-August the ratio sat consistently below 0.80. The shift in options hedging demand is the clearest sign of near-term investor anxiety, even as the short book stays light.
The Street remains constructive in aggregate but has been visibly shaken. Multiple analysts slashed targets following the late-July earnings miss, with RBC Capital cutting from $2,400 to $1,525 while holding an Outperform, and Barclays trimming from $1,950 to $1,700 while keeping an Overweight. UBS, already sidelined at Neutral, lowered its target from $1,200 to $1,130 in mid-August. Wolfe Research moved to a neutral-equivalent Peer Perform outright. Against that wave of caution, Wells Fargo went the other way and edged its target slightly higher to $1,450, and Needham held firm with a Buy and a $1,650 target. The resulting consensus mean price target of $1,464 implies roughly 57% upside from current levels — but that gap is as much a reflection of how far the stock has fallen as it is a statement of conviction. The bull case centres on FICO's structural dominance in credit scoring and the pricing power that flows from it, plus a $1.5 billion accelerated share repurchase. The bear case is simpler: the business is cyclically exposed to mortgage and lending volumes, and any deterioration in financial-institution activity hits both the Scores and Software segments simultaneously. Factor scores do little to resolve the debate — EPS momentum rankings sit in the low 40s, the forward-earnings growth rank is at just 27, and the analyst recommendation differential scores in the bottom decile of the universe.
Ownership data adds a layer of nuance. Capital Research and Management entered a 13G filing on August 12, disclosing a 5.6% stake through Capital Research Global Investors and a separate 5.4% through Capital International Investors — a combined footprint approaching 11% of shares. The firm is already the largest institutional holder at roughly 15% when including separately managed accounts. BlackRock and the Vanguard entities round out the top of the register with broadly stable positions. On the insider side, the 90-day net figure is modestly negative — one director completed a pre-arranged 10b5-1 sale of $1.35 million in late July — but there is no pattern of discretionary selling. Option exercises and compensation-related transactions dominate the recent activity, including director Braden Kelly's series of option exercises in late August at prices ranging from $391 to $475 per share — well below where the stock is trading today, though the transaction-type codes indicate these are mechanics of the compensation cycle rather than market conviction.
What to watch through November is whether the analyst community meaningfully revises targets lower to close the gap with the current price — right now the Street is holding a constructive line that the stock's own trajectory has put under considerable pressure.
See the live data behind this article on ORTEX.
Open FICO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
